ArticleCureus2026
Epidemiology, Clinical Spectrum, and Serotype Distribution of NS1-Confirmed Dengue Cases in Andhra Pradesh, India: A Decade-Long Retrospective Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDengue is a major public health concern in India, showing marked seasonal variation and diverse clinical manifestations. Long-term regional data are essential for improving early diagnosis and guiding public health interventions. This study assessed decade-long epidemiological trends, clinical spectrum, and dengue virus serotype distribution among NS1-confirmed dengue cases in Andhra Pradesh, India.
methodsWe conducted a retrospective observational study of 30,086 clinically suspected dengue cases tested for dengue NS1 antigen at a tertiary-care center in Andhra Pradesh, India, between January 2015 and December 2024. Demographic characteristics, urban-rural residence, temporal trends, clinical manifestations classified according to the WHO 2009 dengue classification, and dengue virus serotypes were analyzed. Associations were assessed using chi-square tests, and selected comparisons of clinical manifestation categories were performed using proportion-based analyses.
resultsAmong 30,086 suspected cases, 3,899 (13.0%) were NS1-positive. Positivity was higher among males (2,142; 13.6%), children aged ≤18 years (2,235; 20.7%), and rural residents (1,679; 14.7%). Dengue transmission showed consistent post-monsoon peaks from August to October, with a marked decline in 2020 during COVID-19-related movement restrictions. Severe dengue with hemorrhagic manifestations was the most common clinical category (1,734; 44.47%), followed by systemic manifestations (727; 18.64%), neurological involvement (690; 17.68%), gastrointestinal warning signs (307; 7.87%), and hepatic involvement (160; 4.10%). Neurological manifestations were significantly more frequent than gastrointestinal or hepatic involvement. Serotyping of 300 NS1-positive samples showed predominance of dengue virus serotype 3 (111; 37.0%), followed by serotype 2 (70; 23.3%), with mixed serotype infections (28; 9.3%).
conclusionThis decade-long analysis highlights pronounced seasonality, a substantial pediatric burden, rural predominance, evolving dengue virus serotype circulation, and a notable contribution of neurological manifestations to dengue morbidity in southern India. Strengthened pre-monsoon vector control, early syndromic recognition particularly of neurological involvement, and continued molecular serotype surveillance are essential to reduce dengue-related morbidity in endemic regions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.